Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 13.31 is 29% below its 5-year average of 18.70, near the low end of its 5-year range (3.63–48.96).
As of the fiscal period ended Tuesday, June 30, 2026. 6.02% below its 12-month average of 14.17.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 13.31.
QUICK RATIO (ACID-TEST)
13.31
QUICK RATIO (ACID-TEST) AVG TTM
14.17
QUICK RATIO (ACID-TEST) AVG 3Y
15.93
QUICK RATIO (ACID-TEST) AVG 5Y
18.70
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-6.02%
CURRENT VS 3Y AVG
-16.41%
CURRENT VS 5Y AVG
-28.79%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.15
median of 703 covered companies
CURRENT VS SECTOR MEDIAN
+322.67%
vs the sector median at left
LENZ Therapeutics, Inc.
Market Cap
$118.99M
Quick Ratio (Acid-Test)
13.31
TTM Avg
14.17
3Y Avg
15.93
5Y Avg
18.70
Market Cap
$117.53M
Quick Ratio (Acid-Test)
6.49
TTM Avg
6.44
3Y Avg
8.52
5Y Avg
8.53
Market Cap
$116.89M
Quick Ratio (Acid-Test)
1.98
TTM Avg
1.40
3Y Avg
1.60
5Y Avg
1.70
Market Cap
$121.63M
Quick Ratio (Acid-Test)
0.18
TTM Avg
2.21
3Y Avg
2.68
5Y Avg
2.62
Market Cap
$116.34M
Quick Ratio (Acid-Test)
3.36
TTM Avg
3.23
3Y Avg
4.24
5Y Avg
6.08
Market Cap
$116.59M
Quick Ratio (Acid-Test)
2.39
TTM Avg
3.50
3Y Avg
2.69
5Y Avg
1.97
Market Cap
$116.35M
Quick Ratio (Acid-Test)
13.40
TTM Avg
10.04
3Y Avg
7.53
5Y Avg
8.95
Market Cap
$115.36M
Quick Ratio (Acid-Test)
1.31
TTM Avg
1.18
3Y Avg
1.49
5Y Avg
3.22
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LENZ Therapeutics, Inc. (LENZ) | $118.99M | 13.31 | 14.17 | 15.93 | 18.70 |
| Caribou Biosciences, Inc. (CRBU)vs › | $117.53M | 6.49 | 6.44 | 8.52 | 8.53 |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $116.89M | 1.98 | 1.40 | 1.60 | 1.70 |
| TuHURA Biosciences, Inc. (HURA)vs › | $121.63M | 0.18 | 2.21 | 2.68 | 2.62 |
| Foghorn Therapeutics Inc. (FHTX)vs › | $116.34M | 3.36 | 3.23 | 4.24 | 6.08 |
| Cibus, Inc. (CBUS)vs › | $122.13M | 1.62 | 0.78 | 1.43 | 2.39 |
| Genelux Corporation (GNLX)vs › | $116.59M | 2.39 | 3.50 | 2.69 | 1.97 |
| Coya Therapeutics, Inc. (COYA)vs › | $116.35M | 13.40 | 10.04 | 7.53 | 8.95 |
| Lucid Diagnostics Inc. (LUCD)vs › | $115.36M | 1.31 | 1.18 | 1.49 | 3.22 |
| enGene Holdings Inc. (ENGN)vs › | $123.26M | 10.21 | 11.59 | 10.00 | 8.96 |
Quick Ratio
13.31
Excludes inventory
Current Ratio
13.55
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 13.31 |
| 2026-03-31 | 10.26 |
| 2025-12-31 | 14.09 |
| 2025-09-30 | 12.63 |
| 2025-06-30 | 20.54 |
| 2025-03-31 | 23.09 |
| 2024-12-31 | 20.36 |
| 2024-09-30 | 28.63 |
| 2024-06-30 | 23.23 |
| 2024-03-31 | 11.47 |
| 2023-12-31 | 3.63 |
| 2023-09-30 | 5.34 |
| 2023-06-30 | 20.47 |
| 2023-03-31 | 18.85 |
| 2022-12-31 | 4.91 |
| 2022-09-30 | 22.07 |
| 2022-06-30 | 27.07 |
| 2022-03-31 | 26.93 |
| 2021-12-31 | 31.44 |
| 2021-09-30 | 35.60 |
| 2021-06-30 | 48.96 |
| 2021-03-31 | 28.20 |
| 2020-12-31 | 0.66 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
